|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue and Other Income | |||||
| Gross earned premiums | |||||
| Ceded earned premiums | |||||
| Net earned premiums | |||||
| Net investment income | |||||
| Net realized investment gains (losses) | |||||
| Change in fair value of equity securities | |||||
| Gain from VSRM Transaction | |||||
| Loss portfolio transfer risk fee | |||||
| Gain from sale of renewal rights | |||||
| Other gains | |||||
| Agency commission income | |||||
| Other income | |||||
| Change in fair value of contingent considerations | |||||
| Total revenue and other income | |||||
| Expenses | |||||
| Losses and loss adjustment expenses, net | |||||
| Policy acquisition costs | |||||
| Operating expenses | |||||
| Interest expense | |||||
| Total expenses | |||||
| Equity earnings (losses) in Affiliate, net of tax | |||||
| Income (loss) from continuing operations before income taxes | |||||
| Income tax expense (benefit) | |||||
| Net income (loss) from continuing operations | |||||
| Net income from discontinued operations | |||||
| Net income (loss) | |||||
| Preferred stock dividends | |||||
| Series A Preferred Stock Dividends and Redemption premium | |||||
| Net income (loss) allocable to common shareholders | |||||
| Earnings (loss) per common share, basic and diluted | |||||
| Net income (loss) from continuing operations, basic | |||||
| Net income (loss) from continuing operations, diluted | |||||
| Net income from discontinued operations, basic | |||||
| Net income from discontinued operations, diluted | |||||
| Net income (loss) allocable to common shareholders, basic | |||||
| Net income (loss) allocable to common shareholders, diluted | |||||
| Weighted average common shares outstanding, basic | |||||
| Weighted average common shares outstanding, diluted | |||||
Loading...